It doesn't have enough ratings yet to judge what users think.
RayForce is made and published by TAITO Corporation. AppBrain is an independent app data site and isn't affiliated with TAITO Corporation. The app name, icon, screenshots and description belong to TAITO Corporation and are shown as published on the App Store.
About RayForce
RayForce is a games app developed by TAITO Corporation.
User Ratings
RayForce is rated 4.10 out of 5 stars. The rating is based on 10 ratings.
App Information
RayForce costs $6.99. The app size is 51.95 MB. The latest version available is 1.1.4. The last update was on September 6, 2017.
Technical Requirements
The app has a content rating of Everyone. The app has been available on the App Store since January 2012.
More data about RayForce
| Price | $6.99 |
| Rating | 4.10 based on 10 ratings |
| Ranking | Not ranked |
| Version | 1.1.4 |
| App size | 51.9 MB |
| Suitable for | Everyone |
Screenshots
Alternatives to RayForce
More from TAITO Corporation
Changelog of RayForce
No changelog data
Developer information for TAITO Corporation
Address:
Comments on RayForce for iOS
We don't have enough comments to show example comments. Please check back later.
App Store Rankings for RayForce
Technologies used by RayForce
Frequently asked questions about RayForce
Is RayForce free?
No. RayForce costs $6.99 on the App Store.
Is RayForce still available?
Yes. RayForce is on the App Store, and the last update we saw was on September 6, 2017.
How large is RayForce?
RayForce is 51.95 MB.
Is RayForce suitable for children?
App Store rates the content of RayForce as suitable for everyone.
How do people rate RayForce?
RayForce scores 4.10 out of 5 stars, from 10 ratings on the App Store.
Who made RayForce?
RayForce was developed by TAITO Corporation. It is listed in the games category on the App Store.
What are the best alternatives to RayForce?
People looking at RayForce also look at these games apps: DoDonPachi Blissful Death, DoDonPachi Resurrection HD, DEATHSMILES, BLAZING STAR, DoDonPachi Blissful Death AD.